General description
Cefotaxime is a 3rd-generation cephalosporin
INN
Cefotaxime
ATC codes
Medicine type
Chemical agent
Antibiotic groups
EML status history
First added in 2009
(TRS
958)
for
Bacterial infection of unspecified site
Added in 2017
(TRS
1006)
for
Bacterial meningitis
Added in 2017
(TRS
1006)
for
Osteomyelitis or osteitis
Added in 2017
(TRS
1006)
for
Bacterial infection of joint
Added in 2017
(TRS
1006)
for
Sepsis without septic shock
Added in 2017
(TRS
1006)
for
Peritoneal abscess
Added in 2017
(TRS
1006)
for
Peritonitis
Removed in 2017
(TRS
1006)
for
Bacterial infection of unspecified site
Added in 2017
(TRS
1006)
for
Bacterial pneumonia
Added in 2017
(TRS
1006)
for
Other specified pneumonia
Added in 2017
(TRS
1006)
for
Acute pyelonephritis
Added in 2017
(TRS
1006)
for
Inflammatory and other diseases of prostate
Wikipedia
DrugBank
Recommendations
Section
Watch group antibiotics
- Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt)
- Parenteral > General injections > unspecified: 250 mg in vial powder for injection (as sodium salt); 500 mg in vial powder for injection (as sodium salt); 1 g in vial powder for injection (as sodium salt); 2 g in vial powder for injection (as sodium salt)
Indications
First choice
Other specified pneumonia (Hospital-acquired pneumonia) Bacterial meningitis Bacterial pneumonia (Community-acquired pneumonia - severe) [children] co-prescribed with amikacin Acute pyelonephritis (severe) co-prescribed with amikacin Inflammatory and other diseases of prostate (severe) co-prescribed with clarithromycin Bacterial pneumonia (Community-acquired pneumonia - severe) co-prescribed with metronidazole Peritoneal abscess (severe) co-prescribed with metronidazole Peritoneal abscess (mild-moderate) co-prescribed with metronidazole Peritonitis (mild-moderate) co-prescribed with metronidazole Peritonitis (severe)
Other indications